- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02240420
Diabetes Prevention Among Post-partum Women With History of Gestational Diabetes (Star-Mama)
Reaching High Risk Post-partum Women for Nutritional Assessment and Counseling Via a Telephone-based Coaching Program
The purpose of the STAR-MAMA intervention is to develop a patient-tailored telephone-base counseling intervention for young Latino women who are at high risk of diabetes. The intervention will focus at the end of pregnancy and the 9 months post-partum period to improve education and behavioral counseling on nutrition and other related health topics .
The following hypotheses will be formally tested:
Compared with controls at 9 months post-partum:
- Women in the STAR-Moms program will have improved self-reported behavioral outcomes for minutes of physical activity, lower fat diet, and breast-feeding duration (in weeks);
- Women in the STAR-Moms program will have improved diabetes prevention knowledge;
- Women in the STAR-Moms program will have increased diabetes-relevant screening rates.
Women in the STAR-MAMA will have lost more weight than women in the control group.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94110
- San Francisco General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Postpartum Latino women (English or Spanish speakers) with history of gestational diabetes.
- 18 years or older
Exclusion Criteria:
- Do not have type 1 or type 2 diabetes.
- Do not have access to phone line or a cellphone to receive weekly calls of health coaching education over the phone.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Life Style counseling (Star-Mama)
Star-Mama intervention group will receive during 6 months weekly phone calls with queries and narratives about health habits.
The participant's answers will be sent to a health coach who will follow up with the participant, and develop a plan with the participant to address her needs.
|
Participants enrolled in the Star-Mama intervention group will receive 1. weekly automated phone calls with prevention-focused queries (e.g., diet, exercise, breastfeeding).
2. If a participant generates a value rated "out of range," a health coach who receives daily electronic downloads of STAR-Mama responses will call the participant to coach her about the specific health issue.
Participants also hear recorded narratives related to their "out of range" reply encouraging behavior change.
3. Call-backs enable coaches to engage patients in goals setting/action plans and providing information about community resources
Other Names:
|
No Intervention: Educational Resource Support
Participants in the control group of the study will receive a set of educational materials with information about their health and the health of their babies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Behavior change
Time Frame: 6 month -12 months post-partum
|
Women in the intervention arm of the study (Star-Mama) will have behavior changes that lower their risk of developing gestational diabetes in the next pregnancy of type 2 diabetes later in life.
|
6 month -12 months post-partum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight loss
Time Frame: 6-12 months post-partum
|
Women in the intervention arm will have weight losses related to improved behaviors on physical activity, healthier nutrition habits and breastfeeding.
|
6-12 months post-partum
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Margaret A. Handley, MPH, PhD, University of California, San Francisco
Publications and helpful links
General Publications
- Athavale P, Thomas M, Delgadillo-Duenas AT, Leong K, Najmabadi A, Harleman E, Rios C, Quan J, Soria C, Handley MA. Linking High Risk Postpartum Women with a Technology Enabled Health Coaching Program to Reduce Diabetes Risk and Improve Wellbeing: Program Description, Case Studies, and Recommendations for Community Health Coaching Programs. J Diabetes Res. 2016;2016:4353956. doi: 10.1155/2016/4353956. Epub 2016 Oct 26.
- Handley MA, Harleman E, Gonzalez-Mendez E, Stotland NE, Althavale P, Fisher L, Martinez D, Ko J, Sausjord I, Rios C. Applying the COM-B model to creation of an IT-enabled health coaching and resource linkage program for low-income Latina moms with recent gestational diabetes: the STAR MAMA program. Implement Sci. 2016 May 18;11(1):73. doi: 10.1186/s13012-016-0426-2.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CFDA 10.586
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
AstraZenecaRecruiting
-
Daewoong Pharmaceutical Co. LTD.Not yet recruitingT2DM (Type 2 Diabetes Mellitus)
-
Zhongda HospitalRecruitingType 2 Diabetes Mellitus (T2DM)China
Clinical Trials on Life Style Counseling (Star-Mama)
-
Sykehuset Innlandet HFThe Royal Norwegian Ministry of HealthCompleted
-
Clalit Health ServicesCompleted
-
Aga Khan UniversityUniversity of Helsinki; International Diabetes FederationUnknownPrediabetic State & High Risk IndividualsPakistan
-
Finnish Institute for Health and WelfareAcademy of FinlandCompleted
-
University of TurkuUnknownAtherosclerosisFinland
-
Radboud University Medical CenterCompletedCardiovascular DiseasesNetherlands
-
Glostrup University Hospital, CopenhagenLundbeck Foundation; Sygekassernes HelsefondCompletedPhysical Activity | Sedentary Behavior | Life StyleDenmark
-
Helsinki University Central HospitalUniversity of Helsinki; University of Eastern FinlandNot yet recruitingFertility Disorders | Life Style
-
National Taiwan University HospitalNational Science Council, TaiwanUnknownDiabetes MellitusTaiwan